Metoprolol: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
mNo edit summary
Line 5: Line 5:
{{CMG}}
{{CMG}}


===[[Metoprolol indications and usage|Indications and Usage]]===
Lopressor
 
==[[Metoprolol indications and usage|Indications and Usage]]==
==[[Metoprolol dosage and administration|Dosage and Administration]]==
==[[Metoprolol dosage and administration|Dosage and Administration]]==
==[[Metoprolol dosage forms and strengths|Dosage Forms and Strengths]]==
==[[Metoprolol dosage forms and strengths|Dosage Forms and Strengths]]==

Revision as of 16:20, 12 March 2014

Metoprolol
Clinical data
Trade namesLopressor, Toprol-xl
AHFS/Drugs.comMonograph
MedlinePlusa682864
[[Regulation of therapeutic goods |Template:Engvar data]]
Pregnancy
category
  • AU: C
  • US: C (Risk not ruled out)
Routes of
administration
Oral, IV
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability12%
MetabolismHepatic via CYP2D6, CYP3A4
Elimination half-life3-7 hours
ExcretionRenal
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC15H25NO3
Molar mass267.364 g/mol
3D model (JSmol)
Melting point120 °C (248 °F)
  (verify)

For patient information about Metoprolol, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Lopressor

Indications and Usage

Dosage and Administration

Dosage Forms and Strengths

Contraindications

Warnings and Precautions

Adverse Reactions

Drug Interactions

Use in Specific Populations

Overdosage

Description

Clinical Pharmacology

Nonclinical Toxicology

Clinical Studies

How Supplied/Storage and Handling

Patient Counseling Information

Labels and Packages